Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Blood-brain Barrier Permeability in Alzheimer's Disease
Authors not listed
Maastricht University Medical Center · 2012
Abstract
The main aim of the present study is to improve our understanding of the role of blood-brain barrier function in dementia of the Alzheimer's type. The investigators hypothesize that microvascular dysfunction - more specifically "cerebral perfusion and blood-brain barrier leakage" - is a determinant of cognitive decline and cortical atrophy in Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2012). Blood-brain Barrier Permeability in Alzheimer's Disease. <em>Maastricht University Medical Center</em>. https://clinicaltrials.gov/study/NCT01574456
Vancouver
Anonymous. Blood-brain Barrier Permeability in Alzheimer's Disease. Maastricht University Medical Center. 2012.
BibTeX
@misc{anon2012Bloodb,
title = {Blood-brain Barrier Permeability in Alzheimer's Disease},
author = {Anonymous},
journal = {Maastricht University Medical Center},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
US Department of Veterans Affairs 1999
Open access · US-GOV
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Neurochemical Research 1995
Citation only
Neural membrane phospholipids in alzheimer disease
Journal of Cerebral Blood Flow & Metabolism 2015
Open access · OA
The neuropathology and cerebrovascular mechanisms of dementia
Nature Reviews Neurology 2024
Preprint · OA